Antibodies for research

Paroxysmal nocturnal hemoglobinuria (PNH), previously Marchiafava–Micheli syndrome, is an hematopoietic stem cell disorder leading to a partial or absolute deficiency of all glycophosphatidyl-inositol (GPI)-linked protein, that causes an increase in sensitivity to complement-mediated cell destruction.
PNH is characterized by chronic intravascular hemolytic anemia, hemoglobinuria, cytopenias due to bone marrow failure, thrombosis and rarely leukemic transformation.
FLAER is used in a flow cytometry test to diagnose paroxysmal nocturnal hemoglobinuria (PNH).
FLAER is produced by labeling an inactive variant of the protein proaerolysin with Alexafluor® 488 succinimidyl ester. The reagent binds selectively to cell surface GPI-anchored proteins, , but will not bind to PNH cells without having that anchor. It is more sensitive than CD59 and detects abnormal small granulocyte populations.
It's available in liquid and lyophilized format.
Note: FLAER is not suitable for the evaluation of erythrocytes and platelets
PRODUCT | QUANTITY |
---|---|
CL-FL1-C | Powder 25 ug |
CL-FL2-C | Powder 50 ug |
CL-FL1S-C | Liquid 25 ug |
CL-FL2S-C | Liquid 50 ug |
Public Documentation
Related products
2021 © Diagnóstica Longwood SL
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
Más información sobre nuestra política de cookies